Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AM-101
AM-101
0-for-3 in PhIII: Auris’ late-stage changeup fails to save tinnitus drug from another disaster
Endpoints
Tue, 03/13/18 - 09:36 pm
Auris
tinnitus
clinical trials
Keyzilen
AM-101
Auris shares are crushed as tinnitus drug fails PhIII test
Endpoints
Thu, 08/18/16 - 09:01 am
Auris
tinnitus
clinical trials
Keyzilen
AM-101